International Urology and Nephrology

, Volume 49, Issue 7, pp 1177–1182 | Cite as

Segmental ureterectomy is not inferior to radical nephroureterectomy for either middle or distal ureter urothelial cell carcinomas within 3.5 cm

  • Chen Fang
  • Xin Xie
  • Tianyuan Xu
  • Wei He
  • Hongchao He
  • Xiaojing Wang
  • Yu Zhu
  • Zhoujun Shen
  • Yuan Shao
Urology - Original Paper
  • 117 Downloads

Abstract

Objective

To evaluate oncologic outcomes of segmental ureterectomy (SU) compared with radical nephroureterectomy (RNU) for urothelial carcinoma of ureter. To evaluate whether tumor position is a factor to influence outcomes of different surgical procedures.

Methods

From November 2003 to June 2016, 131 patients with urothelial carcinoma of ureter underwent SU or RNU at our department. We used survival analysis and Cox regression models to compare oncologic outcomes after SU and RNU. Covariates included surgical type, tumor stage, cancer grade, lesion position, presence of preoperative hydronephrosis and histories of bladder cancer. Patients were divided according to lesion sites for further comparison.

Results

The mean length of follow-up was 55.3 and 50.9 months for the RNU and SU group, respectively. The bladder recurrences, local recurrences, distant metastasis, cancer-specific survival and overall survival rates showed no significant differences between RNU and SU (p = 0.596, p = 0.636, p = 0.740, p = 0.809, p = 0.553, respectively). For mid-ureter or distal ureter lesions, no significant difference of oncologic outcomes between SU and RUN was observed.

Conclusions

Our study suggested SU is not inferior to RNU for either middle or distal ureter urothelial cell carcinomas.

Keywords

Urothelial carcinoma Segmental ureterectomy Nephroureterectomy Ureter Survival Recurrence 

Notes

Acknowledgements

Funding was provided by National Natural Science Foundation of China (Grant No. 81472379).

References

  1. 1.
    Ito Y, Kikuchi E, Tanaka N (2011) Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma. J Urol 185(5):1621–1626CrossRefPubMedGoogle Scholar
  2. 2.
    Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11–30CrossRefPubMedGoogle Scholar
  3. 3.
    Lucas SM, Svatek RS, Olgin G (2008) Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery. BJU Int 102(2):172–176CrossRefPubMedGoogle Scholar
  4. 4.
    Hung SY, Yang WC, Luo HL (2014) Segmental ureterectomy does not compromise the oncologic outcome compared with nephroureterectomy for pure ureter cancer. Int Urol Nephrol 46(5):921–926CrossRefPubMedGoogle Scholar
  5. 5.
    NCCN guidelines for upper urinary tract carcinoma. http://www.nccn.org
  6. 6.
    Jeldres C, Lughezzani G, Sun M (2010) Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter. J Urol 183(4):1324–1329CrossRefPubMedGoogle Scholar
  7. 7.
    Colin P, Ouzzane A, Pignot G (2012) Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. BJU Int 110(8):1134–1141CrossRefPubMedGoogle Scholar
  8. 8.
    Dalpiaz O, Ehrlich G, Quehenberger F (2013) Distal ureterectomy is a safe surgical option in patients with urothelial carcinoma of the distal ureter. Urol Oncol 32(1):34.e1-8PubMedGoogle Scholar
  9. 9.
    Roupret M, Zigeuner R, Palou J (2012) European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract. Actas Urol Esp 36(1):2–14CrossRefPubMedGoogle Scholar
  10. 10.
    Lane BR, Smith AK, Larson BT (2010) Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 116(12):2967–2973CrossRefPubMedGoogle Scholar
  11. 11.
    Rai BP, Shelley M, Coles B (2012) Surgical management for upper urinary tract transitional cell carcinoma (UUT-TCC): a systematic review. BJU Int 110(10):1426–1435CrossRefPubMedGoogle Scholar
  12. 12.
    Chen GL, Bagley DH (2000) Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. J Urol 164(4):1173–1176CrossRefPubMedGoogle Scholar
  13. 13.
    Huang WC, Elkin EB, Levey AS (2009) Partial nephrectomy versus radical nephrectomy in patients with small renal tumors—is there a difference in mortality and cardiovascular outcomes? J Urol 181(1):55–61 (discussion 61–62) CrossRefPubMedGoogle Scholar
  14. 14.
    Snyder JJ, Collins AJ (2009) Association of preventive health care with atherosclerotic heart disease and mortality in CKD. J Am Soc Nephrol 20(7):1614–1622CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2017

Authors and Affiliations

  • Chen Fang
    • 1
  • Xin Xie
    • 1
  • Tianyuan Xu
    • 1
  • Wei He
    • 1
  • Hongchao He
    • 1
  • Xiaojing Wang
    • 1
  • Yu Zhu
    • 1
  • Zhoujun Shen
    • 1
  • Yuan Shao
    • 1
    • 2
  1. 1.Department of Urology, Ruijin HospitalShanghai Jiaotong University School of MedicineShanghaiChina
  2. 2.Department of Urology, Ruijin Hospital NorthShanghai Jiaotong University School of MedicineShanghaiChina

Personalised recommendations